Appointment booking for Dr. Sheetal Acharya, MD is currently not available.Dr. Sheetal Acharya, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Sheetal Acharya, MD (she/her) is a Oncologist in Marquette, MI with over 18 years of experience. What is your opinion of Dr. Sheetal Acharya, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sheetal Acharya, MD has received over $1,022 which includes payments from the following companies:
$221.89 from Celgene Corporation
$152.06 from Amgen Inc.
$108.67 from Novartis Pharmaceuticals Corporation
$106.72 from Genentech USA, Inc.
$86.62 from GlaxoSmithKline, LLC.
$69.29 from Janssen Scientific Affairs, LLC
$64.21 from CooperSurgical, Inc.
$45.45 from Millennium Pharmaceuticals, Inc.
$34.74 from Janssen Pharmaceuticals, Inc
$29.02 from E.R. Squibb & Sons, L.L.C.
$21.25 from Janssen Biotech, Inc.
$14.07 from Astellas Pharma US Inc
$12.37 from Alexion Pharmaceuticals, Inc.
$11.80 from Medivation Inc.
$11.42 from Incyte Corporation
$10.94 from LILLY USA, LLC
$10.91 from Seattle Genetics, Inc.
$10.60 from Bayer HealthCare Pharmaceuticals Inc.
Payments received by Dr. Sheetal Acharya, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!